GnRH Agonist and Intrauterine Insemination

This study has been completed.
Sponsor:
Information provided by:
Instituto Valenciano de Infertilidad, Spain
ClinicalTrials.gov Identifier:
NCT00503217
First received: July 17, 2007
Last updated: October 2, 2009
Last verified: October 2009
  Purpose

The aim of this study is to assess whether GnRH agonist administration in the luteal phase improves pregnancy outcome in intrauterine insemination (IUI) cycles.


Condition Intervention Phase
Intrauterine Insemination
Drug: Tryptorelin
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind
Official Title: Effect of GnRH Agonist Administration at the Time of Implantation in Intrauterine Insemination Cycles: A Randomized Controlled Trial

Resource links provided by NLM:


Further study details as provided by Instituto Valenciano de Infertilidad, Spain:

  Eligibility

Ages Eligible for Study:   18 Years to 38 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Women < 38 years old
  • Bilateral tubal patency confirmed by hysterosonography
  • Normal ultrasound scan of uterus and ovaries
  • Normal day 3 basal hormones
  • Motile sperm count after capacitation ≥ 3 mill/ml

Exclusion Criteria:

  • Endometriosis
  • Polycystic ovary syndrome
  • Uterine disease (polyps, myomas and müllerian diseases)
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00503217

Locations
Spain
Instituto Valenciano de Infertilidad Spain
Valencia, Spain, 46015
Sponsors and Collaborators
Instituto Valenciano de Infertilidad, Spain
Investigators
Principal Investigator: Jose Bellver, MD Instituto Valenciano de la Infertilidad
Principal Investigator: Elena Labarta, MD Instituto Valenciano de Infertilidad
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00503217     History of Changes
Other Study ID Numbers: VLC-JB-0205-307-9
Study First Received: July 17, 2007
Last Updated: October 2, 2009
Health Authority: Spain: Ministry of Health

Keywords provided by Instituto Valenciano de Infertilidad, Spain:
intrauterine insemination
GnRH agonist
implantation

Additional relevant MeSH terms:
Deslorelin
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions

ClinicalTrials.gov processed this record on April 15, 2014